Ledger.Open graph →

SEC Form D · filed August 23, 2021

EYEGATE PHARMACEUTICALS INC

Offering

$10.8M

Sold

$10.8M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

WALTHAM, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Paul Chaney · Waltham, MADirector Aron Shapiro · Waltham, MADirector Stephen From · Waltham, MAExec · Director Sarah Romano · Waltham, MAExec Kenneth Gayron · Waltham, MADirector Brian Strem · Waltham, MAExec · Director Praveen Tyle · Waltham, MADirector Justin Jory · Woodbridge, VADirector David Wurtzbacher · Woodbridge, VAExec Yaron Naymark · Westport, CTExec · Director Matthew Wampler · COLLEGEVILLE, PADirector Rodney D. Brown · LEESBURG, VAExec · Director Shravan Parsi · Austin, TXDirector Randy H. Hopkins · Meridian, IDDirector Amir Nashat · CAMBRIDGE, MADirector Paula Ragan · CAMBRIDGE, MADirector Richard Young · CAMBRIDGE, MAExec Josh Mandel-Brehm · CAMBRIDGE, MAExec · Director Daniel Kapnick · Chicago, ILDirector Paul Shufro · Wilton, CTDirector Jeffery Birch · Chicago, ILExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗